Evaluation of BRCA1-related molecular features and microRNAs as prognostic factors for triple negative breast cancers-Reference-Cited by-同舟云学术

Evaluation of BRCA1-related molecular features and microRNAs as prognostic factors for triple negative breast cancers

Published:2015-10-21 Issue:1 Volume:15 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Boukerroucha Meriem,Josse Claire,ElGuendi Sonia,Boujemla Bouchra,Frères Pierre,Marée Raphaël,Wenric Stephane,Segers Karin,Collignon Joelle,Jerusalem Guy,Bours Vincent

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-015-1740-9.pdf

Reference39 articles.

1. Turner N, Tutt A, Ashworth A. Hallmarks of “BRCAness” in sporadic cancers. Nat Rev Cancer. 2004;4(October):814–9.

2. von Minckwitz G, Schneeweiss A, Loibl S, Salat C, Denkert C, Rezai M, et al. Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial. Lancet Oncol. 2014;15:747–56.

3. Byrski T, Huzarski T, Dent R, Marczyk E, Jasiowka M, Gronwald J, et al. Pathologic complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patients. Breast Cancer Res Treat. 2014;147:401–5.

4. Sikov WM, Berry DA, Perou CM, Singh B, Cirrincione CT, Tolaney SM, et al. impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (a. J Clin Oncol. 2015;33:13–21.

5. Tutt A, Robson M, Garber JE, Domchek SM, Audeh MW, Weitzel JN, et al. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial. Lancet. 2010;376:235–44.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of CSNK1D and KLK6 as two common upregulated genes present in BRCA1 mutated triple-negative breast cancer and ovarian epithelial carcinoma;Nucleosides, Nucleotides & Nucleic Acids;2024-05-23

2. MicroRNA as a promising molecular biomarker in the diagnosis of breast cancer;Frontiers in Molecular Biosciences;2024-05-15

3. miR-34a and miR-21 as biomarkers in evaluating the response of chemo-radiotherapy in Egyptian breast cancer patients;Journal of Radiation Research and Applied Sciences;2022-09

4. Exceptional behavior of breast cancer-associated type 1 gene in breast invasive carcinoma;Journal of Cancer Research and Therapeutics;2022

5. Next-Generation Digital Histopathology of the Tumor Microenvironment;Genes;2021-04-07